skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Including "risk assessment"   Just search Risk analysis

Results 1 - 20 of 26,456  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Journal Title: Blood remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL
Material Type:
Article
Add to My Research

Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL

Blood, 2021-09, Vol.138 (11), p.948-958 [Peer Reviewed Journal]

2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020010144 ;PMID: 33895809

Full text available

2
Joint Analyses of Serum Proteins and Circulating Tumor DNA Improves Risk Assessment and Subtype Stratification in Large B-Cell Lymphomas
Material Type:
Article
Add to My Research

Joint Analyses of Serum Proteins and Circulating Tumor DNA Improves Risk Assessment and Subtype Stratification in Large B-Cell Lymphomas

Blood, 2023-11, Vol.142 (Supplement 1), p.3015-3015 [Peer Reviewed Journal]

ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-177849

Full text available

3
p53 Mutant Independently Impacts Risk: Analysis of Deletion 5q, Lower-Risk Myelodysplastic Syndromes (MDS) Patients Treated with Lenalidomide (LEN) in the MDS-004 Study
Material Type:
Article
Add to My Research

p53 Mutant Independently Impacts Risk: Analysis of Deletion 5q, Lower-Risk Myelodysplastic Syndromes (MDS) Patients Treated with Lenalidomide (LEN) in the MDS-004 Study

Blood, 2014-12, Vol.124 (21), p.414-414 [Peer Reviewed Journal]

2014 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V124.21.414.414

Full text available

4
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
Material Type:
Article
Add to My Research

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Blood, 2007-02, Vol.109 (3), p.926-935 [Peer Reviewed Journal]

2007 American Society of Hematology ;2007 INIST-CNRS ;2007 by The American Society of Hematology 2007 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2006-01-024729 ;PMID: 17003380

Full text available

5
Development of a Risk Assessment Model for Cardiac Injury in Patients Newly Diagnosed with Acute Myeloid Leukemia Based on a Multicenter, Real-World Analysis in China
Material Type:
Article
Add to My Research

Development of a Risk Assessment Model for Cardiac Injury in Patients Newly Diagnosed with Acute Myeloid Leukemia Based on a Multicenter, Real-World Analysis in China

Blood, 2023-11, Vol.142 (Supplement 1), p.5855-5855 [Peer Reviewed Journal]

ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-174050

Full text available

6
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation
Material Type:
Article
Add to My Research

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Blood, 2013-02, Vol.121 (6), p.1059-1064 [Peer Reviewed Journal]

2013 American Society of Hematology ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-07-445965 ;PMID: 23247725

Full text available

7
Comparative Risk Assessment of Imatinib, Nilotinib and Dasatinib in Randomized Controlled Trials: A Meta-Analysis
Material Type:
Article
Add to My Research

Comparative Risk Assessment of Imatinib, Nilotinib and Dasatinib in Randomized Controlled Trials: A Meta-Analysis

Blood, 2017-12, Vol.130, p.2869-2869 [Peer Reviewed Journal]

2017 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V130.Suppl_1.2869.2869

Full text available

8
The Analysis of Risk for Solitary Bone Plasmacytoma Rapidly Progressing to Multiple Myeloma
Material Type:
Article
Add to My Research

The Analysis of Risk for Solitary Bone Plasmacytoma Rapidly Progressing to Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.4750-4750 [Peer Reviewed Journal]

2021 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2021-145024

Full text available

9
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
Material Type:
Article
Add to My Research

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

Blood, 2008-11, Vol.112 (9), p.3574-3581 [Peer Reviewed Journal]

2008 American Society of Hematology ;2009 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2008-02-140095 ;PMID: 18606875

Full text available

10
Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients
Material Type:
Article
Add to My Research

Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients

Blood, 2023-11, Vol.142 (Supplement 1), p.3725-3725 [Peer Reviewed Journal]

ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-189629

Full text available

11
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Material Type:
Article
Add to My Research

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

Blood, 2008-04, Vol.111 (8), p.4029-4038 [Peer Reviewed Journal]

2008 American Society of Hematology ;2008 INIST-CNRS ;2008 by The American Society of Hematology 2008 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2007-10-119974 ;PMID: 18263783

Full text available

12
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis
Material Type:
Article
Add to My Research

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Blood, 2017-10, Vol.130 (15), p.1757-1759 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-06-791756 ;PMID: 28768627

Full text available

13
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy
Material Type:
Article
Add to My Research

AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy

Blood, 2006-05, Vol.107 (10), p.3832-3840 [Peer Reviewed Journal]

2006 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2005-09-3600 ;PMID: 16410446

Full text available

14
A Novel, Clinically Adaptable Comorbidity Assessment Tool for Non-Hodgkin Lymphoma (NHL), the Three-Factor Risk Estimate Scale (TRES): Analysis of 40,000 Older Adults Enrolled in SEER-Medicare
Material Type:
Article
Add to My Research

A Novel, Clinically Adaptable Comorbidity Assessment Tool for Non-Hodgkin Lymphoma (NHL), the Three-Factor Risk Estimate Scale (TRES): Analysis of 40,000 Older Adults Enrolled in SEER-Medicare

Blood, 2022-11, Vol.140 (Supplement 1), p.1924-1925 [Peer Reviewed Journal]

2022 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2022-159632

Full text available

15
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial
Material Type:
Article
Add to My Research

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Blood, 2013-05, Vol.121 (20), p.4056-4062 [Peer Reviewed Journal]

2013 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-11-468348 ;PMID: 23535063

Full text available

16
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
Material Type:
Article
Add to My Research

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

Blood, 2000-03, Vol.95 (5), p.1588-1593 [Peer Reviewed Journal]

2000 American Society of Hematology ;2000 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V95.5.1588.005k38_1588_1593 ;PMID: 10688812

Full text available

17
Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy
Material Type:
Article
Add to My Research

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

Blood, 2019-11, Vol.134 (Supplement_1), p.3642-3642 [Peer Reviewed Journal]

2019 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2019-129901

Full text available

18
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
Material Type:
Article
Add to My Research

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Blood, 2012-10, Vol.120 (14), p.2826-2835 [Peer Reviewed Journal]

2012 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-06-435669 ;PMID: 22875911

Full text available

19
Oncology Providers Ability to Prognosticate Patient Outcomes: An Analysis of the Survey on Provider Assessment of Risk (SPAR) Study
Material Type:
Article
Add to My Research

Oncology Providers Ability to Prognosticate Patient Outcomes: An Analysis of the Survey on Provider Assessment of Risk (SPAR) Study

Blood, 2015-12, Vol.126 (23), p.5635-5635 [Peer Reviewed Journal]

2015 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V126.23.5635.5635

Full text available

20
The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies
Material Type:
Article
Add to My Research

The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies

Blood, 2012-03, Vol.119 (10), p.2392-2400 [Peer Reviewed Journal]

2012 American Society of Hematology ;2015 INIST-CNRS ;2012 by The American Society of Hematology 2012 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-10-383448 ;PMID: 22251481

Full text available

Results 1 - 20 of 26,456  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (26,450)

Refine My Results

Creation Date 

From To
  1. Before 1982  (27)
  2. 1982 To 1991  (226)
  3. 1992 To 2001  (653)
  4. 2002 To 2012  (8,729)
  5. After 2012  (16,816)
  6. More options open sub menu

Language 

  1. English  (26,455)
  2. Japanese  (998)
  3. French  (1)
  4. Norwegian  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait